Drug-resistant tuberculosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Tuberculosis}} {{CMG}}; {{AE}} {{AL}} ==Overview== ==MDR== ==XDR== ==XXDR== ==References== {{Reflist|2}}" |
No edit summary |
||
| Line 6: | Line 6: | ||
==MDR== | ==Multiple Drug-Resistant MDR Tuberculosis== | ||
MDR-TB is defined as resistance to isoniazid and rifampicin, with or without resistance to other first-line drugs (FLD). | |||
==XDR== | ==Extensively Drug-Resistant XDR Tuberculosis== | ||
XDR-TB is defined as resistance to at least isoniazid and rifampicin, and to any fluoroquinolone, and to any of the three second-line injectables (amikacin, capreomycin, and kanamycin). | |||
==XXDR== | ==Extremely Drug-Resistant (XXDR) Tuberculosis== | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 14:58, 17 September 2014
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Drug-resistant tuberculosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Drug-resistant tuberculosis medical therapy |
|
Risk calculators and risk factors for Drug-resistant tuberculosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Multiple Drug-Resistant MDR Tuberculosis
MDR-TB is defined as resistance to isoniazid and rifampicin, with or without resistance to other first-line drugs (FLD).
Extensively Drug-Resistant XDR Tuberculosis
XDR-TB is defined as resistance to at least isoniazid and rifampicin, and to any fluoroquinolone, and to any of the three second-line injectables (amikacin, capreomycin, and kanamycin).